alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
_________________________________________ 

 

 

 

Order Michigan Supreme Court

Lansing, Michigan 

September 22, 2008 Clifford W. Taylor,

 Chief Justice 

Michael F. Cavanagh 

Elizabeth A. Weaver 136685 Marilyn Kelly 

Maura D. Corrigan 

Robert P. Young, Jr. 

Stephen J. Markman, 

PEOPLE OF THE STATE OF MICHIGAN, Justices 

Plaintiff-Appellee, 

v SC: 136685 

 COA: 281950 

Jackson CC: 05-007227-FH 

RASHAWN JAMARR PARRIS,

 Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the April 22, 2008 order 

of the Court of Appeals is considered, and it is DENIED, because we are not persuaded 

that the questions presented should be reviewed by this Court. 

d0915 

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

September 22, 2008 

 Clerk
No. 14

- 14

- 00278

- CR

In the 

### Court of Appeals
For the 

### Fourteenth District of Texas

At Houston

No. 1243451 In the 178 th District Court Of Harris County, Texas



### CHADRICK CANARD JOHNSON

Appellant

v. 

### THE STATE OF TEXAS

Appellee



### STATE’S MOTION FOR EXTENSION OF TIME IN WHICH TO FILE APPELLATE BRIEF

TO THE HONORABLE COURT OF APPEALS OF TEXAS:

COMES NOW THE STATE OF TEXAS, in accordance with Rules 10.5(b)(1) and

38.6(d) of the Texas Rules of Appellate Procedure, and files this motion for extension of

time in which to file the State’s brief in this case, and, in support thereof, presents the

following: ACCEPTED 14-14-00278-CR FOURTEENTH COURT OF APPEALS

HOUSTON, TEXAS 12/29/2014 7:21:35 AM CHRISTOPHER PRINE

CLERK1. In the 178 th District Court of Harris Count y, Texas, in cause number 1243451

,

The State of Texas v. Chadrick Canard Johnson , Ap pellant was convicted of murder

,

and was sentenced to forty five years in the Texas Department of C riminal Justice

,

Correctional Institutions Division

, on March 19 , 2 014

.

2

. A w ritten notice of appeal w as timely filed on March 19, 2014

.

4. The State’s brief was due on December 22 , 2014

. 5. An extension of time in which to file the State’s brief is requested until January 22

, 2014 5

6. Two previous extension s of time have been requested by the State.

7. The facts relied upon to explain the need for this extension are:

The State’s Assistant District Atto rney on appeal is finalizing a brief for submission in Ibarra v. State, 14

- 14

- 00471

- CR

. The State’s Assistant District Attorney on appeal was ordered to active duty in the United States Navy from December 26, 2014 through January 4, 2015 ; this period of active duty service will delay the work on all assigned briefs

. Additional time will be n ecessary to submit previously assigned briefs prior to submission of this brief.

WHEREFORE, the State prays that this Court will grant an extension of time until

January 22 , 2015 in which to fil e the State’s brief in th is case

.

Respectfully submitted,

SETH GAGLIARDI Assistant District Attorney Harris County, Texas 1201 Franklin, Suite 600 Houston, Texas 77002 (713) 755

- 5826 TBC No. 24073207CERTIFICATE OF SERVICE

This is to certify that a copy of the foregoing instrument has been emailed and faxed

to the attorney for the Appellant on December 29, 2014 :
Glenn Youngblood 5555 South Loop West, Suite 396 Bellaire, TX 77401 Phone: (713) 432

- 1013 Fax: ( 713) 574

- 3042 Em ail: glenlaw1@comcast.net

SETH GAGLIARDI Assistant District Attorney Harris County, Texas 1201 Franklin, Suite 600 Houston, Texas 77002 (713) 755

- 5826 TBC No. 24073207

Date: December 29, 2014
Sukhjit BHATTI, Appellant, v. LAVIGNE OIL COMPANY OF FLORIDA, LLC, & City Market 24-7, LLC, Appellees.

No. 1D17-2018

District Court of Appeal of Florida, First District.

February 22, 2018 Rehearing Denied March 29, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2827 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2827

          To extend the suspension of duty on Basic Violet 1.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

   Mr. Kerry introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
          To extend the suspension of duty on Basic Violet 1.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. BASIC VIOLET 1.

    (a) In General.--Heading 9902.23.60 of the Harmonized Tariff 
Schedule of the United States (relating to Basic Violet 1) is amended 
by striking the date in the effective period column and inserting ``12/
31/2015''.
    (b) Effective Date.--The amendment made by this section applies to 
goods entered, or withdrawn from warehouse for consumption, on or after 
the 15th day after the date of the enactment of this Act.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM FINANCIAL
STATEMENT OF CITADEL TECHNOLOGY, INC. FOR THE PERIOD ENDED AUGUST 31, 1998 AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          FEB-28-1999
<PERIOD-START>                             MAR-01-1998
<PERIOD-END>                               AUG-31-1998
<CASH>                                       1,930,876
<SECURITIES>                                         0
<RECEIVABLES>                                1,651,622
<ALLOWANCES>                                         0
<INVENTORY>                                    116,706
<CURRENT-ASSETS>                             4,685,701
<PP&E>                                               0
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                               9,859,086
<CURRENT-LIABILITIES>                        1,950,095
<BONDS>                                         74,910
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                         67
<COMMON>                                       320,404
<OTHER-SE>                                   7,513,610
<TOTAL-LIABILITY-AND-EQUITY>                 9,859,086
<SALES>                                      1,077,318
<TOTAL-REVENUES>                             1,077,318
<CGS>                                           60,912
<TOTAL-COSTS>                                   60,912
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              30,847
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                          (910,031)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                205,847
<CHANGES>                                            0
<NET-INCOME>                                 (704,184)
<EPS-PRIMARY>                                    (.03)
<EPS-DILUTED>                                    (.03)
        

</TABLE>
Opinion filed November 17 , 201 1



## In The 

# Eleventh Court of Appeals

__________



### No. 11

- 11

- 00299

- CV

__________
CHRISTOPHER MARTINEZ, A ppellant

V.

ANDREA DE LA CRUZ, A ppellee

On Appeal from the 161st District Court

Ector County, Texas

Trial Court Cause No . B

- 114,187

M E M O R A N D U M O P I N I O N

Upon receiving the docketing statement and a copy of the notice of appeal, it became
apparent to this court that no final, appealable order had been entered by the trial court because
appellant’s counsel, Sydney S. Weaver, is attempti ng to appeal an order disqualifying her.
Accordingly, the clerk of this court wrote appellant ’s counsel on October 20, 2011, informing

h er that it did not appear that this court had jurisdiction because of the absence of an appealable

order. The clerk’s letter directed appellant ’s counsel to respond in writing by November 4, 2011,
and show grounds to continue this appeal. The clerk’s letter also notified appellant ’s counsel2

that the appeal may be dismissed pursuant to T EX

. R. A PP

. P. 42. See Rule 42.3. Appellant ’s

counsel responded to the clerk’s letter by filing a mandamus, but she has not show n grounds to
continue this appeal.
Appellate courts have jurisdiction over final judgments and only those interlocutory
orders deemed appealable by the Texas Le gislature. Lehmann v. Har

- C on Corp. , 39 S.W.3d

191, 195 (Tex. 2001); City of Houston v. Kilburn , 849 S.W.2d 810, 811 (Tex. 1993); see T EX

. C IV

. P RAC

. & R EM

. C ODE A NN

. § § 15.003

, 51.014(a), (d) (West Supp. 2011 ). A judgment is
final for purposes of appeal if it disposes of all pending parties and claims in the record.

Lehmann , 39 S.W.3d at 195. There is no final judgment on the merits in this cause

, and the
underlying action remains pending. Furthermore, there is no statutory exception that allows
appell ant ’s counsel to appeal the trial court’s interlocutory order disqualifying counsel. See

Lehmann , 39 S.W.3d at 195; City of Houston , 849 S.W.2d at 811.
Consequently, we dismiss this appeal for want of jurisdiction.

PER CURIAM

November 17

, 2011
Panel consists of: Wright, C.J., McCall, J., and Kalenak , J.
---

Exhibit 13.2

CERTIFICATION PURSUANT TO18 U.S.C. §1350,AS ADOPTED
PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Cardero Resource Corp. (the Company)
on Form 20-F for the fiscal year ended October 31, 2013 as filed with the
Securities and Exchange Commission on the date hereof (the Report), I, Blaine
Bailey, the Chief Financial Officer of the Company, certify, pursuant to 18
U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:

| | 1. | The Report fully complies with the requirements of
      Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
  and                                   
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------
| |    |                                                                                                                                                                 
| | 2. | The information contained in the Report fairly presents,
      in all material respects, the financial condition and results of
      operations of the Company.

Date: May 6, 2014

| | /s/
      Blaine Bailey
| | -----------------------
| | Blaine Bailey,         
| | Chief Financial Officer

---
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          JAN-30-1998
<PERIOD-START>                             JUL-01-1997
<PERIOD-END>                               MAR-31-1998
<CASH>                                           9,405
<SECURITIES>                                       250
<RECEIVABLES>                                      656
<ALLOWANCES>                                       126
<INVENTORY>                                        557
<CURRENT-ASSETS>                                12,619
<PP&E>                                          79,663
<DEPRECIATION>                                  33,742
<TOTAL-ASSETS>                                  59,396
<CURRENT-LIABILITIES>                           24,377
<BONDS>                                          4,170
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           345
<OTHER-SE>                                      30,504
<TOTAL-LIABILITY-AND-EQUITY>                    59,396
<SALES>                                          6,211
<TOTAL-REVENUES>                                43,167
<CGS>                                            5,596
<TOTAL-COSTS>                                   26,168
<OTHER-EXPENSES>                                18,006
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,680
<INCOME-PRETAX>                                (2,416)
<INCOME-TAX>                                     (811)
<INCOME-CONTINUING>                            (1,605)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (1,605)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
```

                                                                  Exhibit 99.1

                          **CERTIFICATION PURSUANT TO
                           18 U.S.C. SECTION 1350,
                            AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 on**

In connection  with the Quarterly  Report of Sierra Health  Services,  Inc. (the
Company) on Form 10-Q for the period ending September 30, 2002 as filed with the
Securities and Exchange  Commission on the date hereof (the Report),  I, Anthony
M. Marlon, M.D., Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C.  Section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that:

The Report fully complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

The  information  contained  in the  Report  fairly  presents,  in all  material
respects, the financial condition and results of operations of the Company.

/s/ Anthony M. Marlon, M.D.
---------------------------
Anthony M. Marlon, M.D.
November 14, 2002
```
Exhibit 10.4
​
Schedule of the Owners of Company-Managed Texas Roadhouse Restaurants and the
Interests Held by Directors, Executive Officers and 5% Stockholders Who Are Parties to
Limited Partnership Agreements and Operating Agreements
​
As of December 28, 2021
​
	​


	​


	​


	​


	​


	​


	​


	​


	​


	​



	Entity Name
	    
	Restaurant Location
	    
	Percentage of
Holdings' Interest
	    
	Actual Management Fee
Charged
	    
	Percentage Owned by
Executive Officers,
Directors & 5%
Stockholders
	​

	​
	​
	​
	​
	​
	​
	​
	​
	​
	​

	Texas Roadhouse of Billings, LLC 
	​
	Billings, MT
	​
	5.0
	%  
	0.5
	%  
	27.5
	%(1)

	​
	​
	​
	​
	​
	​
	​
	​
	​
	​

	Texas Roadhouse of Brownsville, Ltd.
	​
	Brownsville, TX
	​
	5.09
	%
	0.5
	%
	3.06
	%(2)

	​
	​
	​
	​
	​
	​
	​
	​
	​
	​

	Texas Roadhouse of Everett, LLC 
	​
	Everett, MA
	​
	5.0
	%  
	0.5
	%  
	28.75
	%(1)

	​
	​
	​
	​
	​
	​
	​
	​
	​
	​

	Texas Roadhouse of Gilbert, AZ, LLC 
	​
	Gilbert, AZ
	​
	52.5
	%
	3.5
	%
	41.5
	%(3)

	​
	​
	​
	​
	​
	​
	​
	​
	​
	​

	Texas Roadhouse of Mansfield, Ltd.
	​
	Mansfield, TX
	​
	52.5
	%
	3.5
	%
	34.5
	%(2)

	​
	​
	​
	​
	​
	​
	​
	​
	​
	​

	Roadhouse of McKinney, Ltd.
	​
	McKinney, TX
	​
	5.0
	%
	0.5
	%
	2.0
	%(2)

	​
	​
	​
	​
	​
	​
	​
	​
	​
	​

	Texas Roadhouse of Port Arthur, Ltd. 
	​
	Port Arthur, TX
	​
	5.0
	%  
	0.5
	%  
	15.0
	%(1)

	​
	​
	​
	​
	​
	​
	​
	​
	​
	​

	Roadhouse of Kansas, LLC 
	​
	Wichita, KS
	​
	5.0
	%  
	0.5
	%  
	24.05
	%(1)





	(1)
	The ownership percentages listed for these restaurants are owned by the Estate of W. Kent Taylor.


​
	(2)
	The ownership percentages listed for these restaurants are owned by Gerald L. Morgan, the Company’s Chief Executive Officer and President.


​
	(3)
	The ownership percentage listed for this restaurant is owned by Douglas W. Thompson, the Company’s former Chief Operating Officer.
Exhibit 4.5


 


DESCRIPTION OF SECURITIES


 


The following is a summary of the rights of
our capital stock as provided in our certificate of incorporation, bylaws and certificate of designation


 


General


 


The Company is authorized to issue two classes
of stock. The total number of shares of stock which the Company is authorized to issue is One Billion One Hundred Ten Million (1,110,000,000)
shares of capital stock, consisting of One Billion One Hundred Million (1,100,000,000) shares of Common Stock, $0.001 par value and Ten
Million (10,000,000) shares of preferred stock, $0.001 par value (the “Preferred Stock”).


 


Common Stock


 


As of the date of this Form 10-K, the Company
had 100,000,000 shares of Common Stock issued and outstanding.


 


Voting


 


The holders of the Common Stock are entitled to
one vote for each share held at all meetings of shareholders (and written actions in lieu of meeting). There shall be no cumulative voting.
The holders of shares of Common Stock are entitled to dividends when and as declared by the Board from funds legally available therefor,
and upon liquidation are entitled to share pro rata in any distribution to holders of Common Stock. There are no preemptive, conversion
or redemption privileges, nor sinking fund provisions with respect to the Common Stock.


 


Changes in Authorized Number


 


The number of authorized shares of Common Stock
may be increased or decreased subject to the Company’s legal commitments at any time and from time to time to issue them, by the
affirmative vote of the holders of a majority of the stock of the Company entitled to vote.


 


Preferred Stock


 


The Preferred Stock may be issued from time to
time in one or more series. The Board is authorized to fix the number of shares of any series of Preferred Stock and to determine the
designation of any such series. The Board is also authorized to determine or alter the rights, preferences, privileges, and restrictions
granted to or imposed upon any wholly unissued series of Preferred Stock and, within the limits and restrictions stated in any resolution
or resolutions of the Board originally fixing the number of shares constituting any series, to increase or decrease (but not below the
number of shares of such series than outstanding) the number of shares of any such series subsequent to the issue of shares of that series.


 


Currently, no preferred shares have been designated
or issued.
EXHIBIT 99.1 - ANNUAL FUNDS APPLICATION STATEMENT




                              [LOGO] JPMORGAN


June 30, 2005

    Hartford Life Global Funding Trusts - Annual Funds Application Statement

I, Albert P. Mari, Jr., being a duly appointed officer of JPMorgan Chase Bank,
N.A. ("Indenture Trustee"), do hereby certify on behalf of the Indenture
Trustee, that, with respect to Hartford Life Global Funding Trust 2004-003:





         1. I have reviewed and examined the application by the Indenture
Trustee, during the fiscal year ending June 15, 2005; of trust money collected
by the Indenture Trustee pursuant to Section 5.02 of the Indenture, pursuant to
which the trust's notes (the "Notes") were issued; and

         2. Based upon my review and examination, to the best of my knowledge,
during such fiscal year, the trust money collected by the Indenture Trustee was
properly applied, pursuant to Section 5.02 of the Indenture.

         Nothing herein shall constitute a representation as to the proper
application by the registered holder of the Notes or the trust of the trust
monies received by it.



JPMORGAN CHASE BANK, N.A., as Indenture Trustee
Worldwide Securities Services
4 New York Plaza, 15th Floor
New York, NY 10004


/s/ Albert P. Mari, Jr.


Name:  Albert P. Mari, Jr.
Title: Vice President


<TABLE>
<S><C>
JPMORGAN CHASE BANK o Institutional Trust Services o 4 New York Plaza, Floor 15, New York, NY 10004
</TABLE>
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 2646 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 2646

   To suspend temporarily the duty on ascorbic acid encapsulated in 
                      cellulose acetate butyrate.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 7, 2012

 Ms. Klobuchar introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
   To suspend temporarily the duty on ascorbic acid encapsulated in 
                      cellulose acetate butyrate.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ASCORBIC ACID ENCAPSULATED IN CELLULOSE ACETATE BUTYRATE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      Ascorbic acid (CAS  Free         No change        No change        On or before 12/  ''.
                        No. 50-81-7)                                                       31/2015.......
                        encapsulated in
                        cellulose acetate
                        butyrate (CAS No.
                        9004-36-8)
                        (provided for in
                        subheading
                        3815.90.50)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```